Vol 10, Supp. A (2019)
Case report
Published online: 2019-08-23

open access

Page views 536
Article views/downloads 334
Get Citation

Connect on Social Media

Connect on Social Media

The coexistence of Hodgkin lymphoma and myelofibrosis in a patient treated with ruxolitinib

Maria Cioch1


Philadelphia-negative myeloproliferative neoplasms are associated with increased risk of lymphoid neoplasms. In this article a female patient with essential thrombocythemia and Hodgkin lymphoma was reported. When remission of lymphoma was obtained secondary myelofibrosis was developed. Therapy with ruxolitinib resulted in resolution of constitutional symptoms and reduction of spleen volume in a short period of time.

Article available in PDF format

View PDF (Polish) Download PDF file

Hematology in Clinical Practice